Epigral (EPIGRAL) Stock Overview
Manufactures and sells chlor-alkali and related derivatives in India and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 5/6 |
| Past Performance | 5/6 |
| Financial Health | 6/6 |
| Dividends | 3/6 |
Rewards
Risk Analysis
No risks detected for EPIGRAL from our risk checks.
EPIGRAL Community Fair Values
Create NarrativeSee what 7 others think this stock is worth. Follow their fair value or set your own to get alerts.
Epigral Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹1,245.80 |
| 52 Week High | ₹2,114.00 |
| 52 Week Low | ₹1,212.80 |
| Beta | -0.18 |
| 1 Month Change | -14.78% |
| 3 Month Change | -28.96% |
| 1 Year Change | -31.32% |
| 3 Year Change | 3.66% |
| 5 Year Change | n/a |
| Change since IPO | 206.51% |
Recent News & Updates
Returns On Capital At Epigral (NSE:EPIGRAL) Have Hit The Brakes
Dec 26
Downgrade: What You Need To Know About The Latest Epigral Limited (NSE:EPIGRAL) Forecasts
Nov 16Epigral Limited Just Missed Earnings - But Analysts Have Updated Their Models
Nov 13If EPS Growth Is Important To You, Epigral (NSE:EPIGRAL) Presents An Opportunity
Nov 11Recent updates
Returns On Capital At Epigral (NSE:EPIGRAL) Have Hit The Brakes
Dec 26Downgrade: What You Need To Know About The Latest Epigral Limited (NSE:EPIGRAL) Forecasts
Nov 16Epigral Limited Just Missed Earnings - But Analysts Have Updated Their Models
Nov 13If EPS Growth Is Important To You, Epigral (NSE:EPIGRAL) Presents An Opportunity
Nov 11Epigral (NSE:EPIGRAL) Has A Pretty Healthy Balance Sheet
Sep 28Epigral Limited Just Recorded A 98% EPS Beat: Here's What Analysts Are Forecasting Next
Aug 06Epigral Limited (NSE:EPIGRAL) Might Not Be As Mispriced As It Looks
Jul 30Investors Should Be Encouraged By Epigral's (NSE:EPIGRAL) Returns On Capital
Jun 02Subdued Growth No Barrier To Epigral Limited (NSE:EPIGRAL) With Shares Advancing 25%
Apr 03Calculating The Fair Value Of Epigral Limited (NSE:EPIGRAL)
Feb 28
Doubling CPVC And ECH Production Will Strengthen Future Prospects
Epigral is expanding production capacity and focusing on high-margin value-added products to enhance earnings and future growth.Here's Why Epigral (NSE:EPIGRAL) Has Caught The Eye Of Investors
Dec 18Epigral Limited's (NSE:EPIGRAL) Shares Leap 29% Yet They're Still Not Telling The Full Story
Jul 04Epigral Limited (NSE:EPIGRAL) Looks Just Right With A 27% Price Jump
Apr 19Epigral Limited (NSE:EPIGRAL) Soars 28% But It's A Story Of Risk Vs Reward
Feb 23Epigral (NSE:EPIGRAL) Might Be Having Difficulty Using Its Capital Effectively
Feb 21Capital Investment Trends At Meghmani Finechem (NSE:MFL) Look Strong
Apr 05With EPS Growth And More, Meghmani Finechem (NSE:MFL) Makes An Interesting Case
Sep 28Meghmani Finechem's (NSE:MFL) Promising Earnings May Rest On Soft Foundations
May 03Meghmani Finechem Limited's (NSE:MFL) Business Is Yet to Catch Up With Its Share Price
Nov 22Shareholder Returns
| EPIGRAL | IN Chemicals | IN Market | |
|---|---|---|---|
| 7D | -2.5% | 0.5% | 1.5% |
| 1Y | -31.3% | -0.8% | 2.0% |
Return vs Industry: EPIGRAL underperformed the Indian Chemicals industry which returned -1.2% over the past year.
Return vs Market: EPIGRAL underperformed the Indian Market which returned 1% over the past year.
Price Volatility
| EPIGRAL volatility | |
|---|---|
| EPIGRAL Average Weekly Movement | 3.9% |
| Chemicals Industry Average Movement | 4.8% |
| Market Average Movement | 5.2% |
| 10% most volatile stocks in IN Market | 8.5% |
| 10% least volatile stocks in IN Market | 3.0% |
Stable Share Price: EPIGRAL has not had significant price volatility in the past 3 months compared to the Indian market.
Volatility Over Time: EPIGRAL's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2007 | 1,072 | Kaushal Soparkar | www.epigral.com |
Epigral Limited manufactures and sells chlor-alkali and related derivatives in India and internationally. The company offers chlorinated polyvinyl chloride (CPVC) resins and compounds, epichlorohydrin, chloromethanes value chain, hydrogen peroxide, caustic soda and potash, chlorine, hydrogen, chloromethanes, captive power plant (CPP), and chlorotoluene value chain, as well as operates wind-solar hybrid power plant. Its products are used in CPVC pipes and fittings, windmills, construction, paints and coatings, electronics, water treatment, agrochemicals, pharmaceuticals, refineries, soap and detergents, fluoropolymers, paper and pulp, textiles, alumina, polyurethane foam, lithium, and polytetrafluoroethylene (PTFE) pipes.
Epigral Limited Fundamentals Summary
| EPIGRAL fundamental statistics | |
|---|---|
| Market cap | ₹53.75b |
| Earnings (TTM) | ₹4.02b |
| Revenue (TTM) | ₹24.67b |
Is EPIGRAL overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| EPIGRAL income statement (TTM) | |
|---|---|
| Revenue | ₹24.67b |
| Cost of Revenue | ₹14.44b |
| Gross Profit | ₹10.22b |
| Other Expenses | ₹6.20b |
| Earnings | ₹4.02b |
Last Reported Earnings
Sep 30, 2025
Next Earnings Date
n/a
| Earnings per share (EPS) | 93.28 |
| Gross Margin | 41.44% |
| Net Profit Margin | 16.31% |
| Debt/Equity Ratio | 25.3% |
How did EPIGRAL perform over the long term?
See historical performance and comparisonDividends
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/01/02 02:49 |
| End of Day Share Price | 2026/01/02 00:00 |
| Earnings | 2025/09/30 |
| Annual Earnings | 2025/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Epigral Limited is covered by 3 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| null null | BP Wealth Management Private Limited |
| null null | Emkay Global Financial Services Ltd. |
| Meet Vora | Emkay Global Financial Services Ltd. |